Testing effectiveness (Phase 2)UnknownNCT00003257What this trial is testingGene Therapy in Treating Patients With Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Aventis Pharmaceuticals 39
Testing effectiveness (Phase 2)UnknownNCT00690872What this trial is testingGemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal CancerWho this might be right forHead and Neck Cancer National Cancer Centre, Singapore 35
Early research (Phase 1)Study completedNCT03590054What this trial is testingAbexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesWho this might be right forStage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more Rahul Aggarwal 35
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 120
Early research (Phase 1)Study completedNCT00011778What this trial is testingPS-341 and Radiation to Treat Advanced Cancer of the Head and NeckWho this might be right forSquamous Cell Carcinoma National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00021424What this trial is testingVaccine Therapy in Treating Patients With Stage IV Head and Neck CancerWho this might be right forHead and Neck CancerMetastatic Cancer National Institute on Deafness and Other Communication Disorders (NIDCD)
Testing effectiveness (Phase 2)Looking for participantsNCT06047379What this trial is testingSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisWho this might be right forDiffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more Neonc Technologies, Inc. 134
Early research (Phase 1)Ended earlyNCT03809624What this trial is testingStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerWho this might be right forMetastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more Inhibrx Biosciences, Inc 160
Large-scale testing (Phase 3)Study completedNCT02252042What this trial is testingPembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)Who this might be right forHead and Neck Squamous Cell Cancer Merck Sharp & Dohme LLC 495
Testing effectiveness (Phase 2)UnknownNCT00589186What this trial is testingVaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal CancerWho this might be right forHead and Neck Cancer National Cancer Centre, Singapore 35
Large-scale testing (Phase 3)UnknownNCT02891083What this trial is testingAdjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal CancerWho this might be right forEsophageal Neoplasms Shanghai Chest Hospital 486
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205What this trial is testingA Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Who this might be right forUnresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer BioNTech SE 358
Testing effectiveness (Phase 2)Looking for participantsNCT05910827What this trial is testingA Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell CancersWho this might be right forAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinoma+4 more Hummingbird Bioscience 398
Testing effectiveness (Phase 2)Study completedNCT01608022What this trial is testingA Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusWho this might be right forEsophageal Squamous Cell Carcinoma Yonsei University 48
Testing effectiveness (Phase 2)Study completedNCT03274011What this trial is testingEfficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Neoplasms Fudan University 40
Large-scale testing (Phase 3)Looking for participantsNCT07264075What this trial is testingStudy Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHNWho this might be right forSquamous Cell Carcinoma Head and Neck Cancer (HNSCC) Groupe Oncologie Radiotherapie Tete et Cou 780
Large-scale testing (Phase 3)Study completedNCT00002507What this trial is testingRadiation Therapy and Chemotherapy in Treating Patients With Head and Neck CancerWho this might be right forCarcinoma of Unknown PrimaryHead and Neck Cancer Yale University
Early research (Phase 1)Study completedNCT00006107What this trial is testingChemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT05673577What this trial is testingCamrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC PatientsWho this might be right forSquamous Cell Carcinoma of Head and Neck Fudan University 41
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53